Displaying 10 out of 28 results

  1. The GSK logo on the facade of GSK Asia House is seen through vertical louvres in Singapore

    GSK to partner with Vir for potential COVID-19 treatments, invest US$250 million

    British drugmaker GlaxoSmithKline Plc will invest US$250 million in Vir Biotechnology Inc and collaborate to develop potential treatments for ...
  2. Logo of U.S. pharmaceutical corporation Pfizer Inc. is seen in Zurich

    Exclusive: Drugmakers from Pfizer to GSK to hike US prices on over 200 drugs

    Drugmakers including Pfizer Inc, GlaxoSmithKline PLC and Sanofi SA are planning to hike prices on more than 200 drugs in the United States on ...
  3. A GSK logo is seen at the GSK research centre in Stevenage

    US FDA declines to approve GSK drugs division's long acting HIV injection

    GlaxoSmithKline's HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long ...
  4. A GSK logo is seen at the GSK research centre in Stevenage

    Britain's GSK seeks U.S approval for rival to J&J's multiple myeloma drug

    GlaxoSmithKline said on Monday it had applied for U.S. approval for its experimental multiple myeloma drug that showed meaningful response in ...
  5. FILE PHOTO: A GSK logo is seen on a flag at a GSK research centre in Stevenage

    GSK seeks FDA approval for investigational HIV treatment

    GlaxoSmithKline Plc said on Thursday its HIV unit has submitted a new drug application to the U.S. Food and Drug Administration seeking approval ...
  6. FILE PHOTO: The GSK logo is seen on top of GSK Asia House in Singapore

    GSK eyes 'step change' in shingles vaccine output in 2024

    GlaxoSmithKline said further growth from its shingles vaccine, which has boosted earnings, would be reined in by limited capacity until 2024, but ...